CME

Ensuring Optimal IBD Care in the Era of COVID-19
Novel Therapeutic Approaches To IBD: Considerations for Optimal Positioning in Clinical Practice
Making the Switch: The Use of Biosimilars in IBD Management
Personalized Therapy in IBD: Decoding Disease Heterogeneity and Real-World Evidence
Personalized Approach to IBD: Treating to Target With New and Emerging Therapies
Recognizing, Treating, and Preventing Recurrence of Clostridium difficile Infection (CDI) in Patients With IBD
Lunch Symposium: Personalized Therapy in IBD: Treating Target to Target with New and Emerging Therapies
Breakfast Symposium: Making the Switch: The Use of Biosimilars in IBD Management
Breakfast Symposium: Novel Therapeutic Approaches to IBD: Considerations for Optimal Positioning in Clinical Practice
Lunch Symposium: Recognizing, Treating, and Preventing Recurrence of Clostridium difficile Infection in Patients with IBD
Back to Top